Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
World Journal of Urology
Published September 13, 2026
Global, regional, and national burden of urolithiasis among children and adolescents, 1990-2021, ...
September 14, 2026
Medspoke
Medspoke
BJU International
Published September 13, 2026
00:00
--:--
Intermittent enzalutamide in recurrent prostate cancer: testosterone kinetics and related toxicity.
September 14, 2026
Share
Intermittent enzalutamide in recurrent prostate cancer: testosterone kinetics and related toxicity.
https://www.medspoke.co/channel_journal?id=689&tap_id=13886
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
BJU International
Published September 13, 2026
Prospective randomised double-blind trial: holmium laser lithotripsy with vs without Moses™ 2.0.
September 14, 2026
Why are you reporting this TALK?
